262 related articles for article (PubMed ID: 12505686)
1. Cannabinergic ligands.
Palmer SL; Thakur GA; Makriyannis A
Chem Phys Lipids; 2002 Dec; 121(1-2):3-19. PubMed ID: 12505686
[TBL] [Abstract][Full Text] [Related]
2. From cannabis to cannabinergics: new therapeutic opportunities.
Goutopoulos A; Makriyannis A
Pharmacol Ther; 2002 Aug; 95(2):103-17. PubMed ID: 12182958
[TBL] [Abstract][Full Text] [Related]
3. Conformational requirements for endocannabinoid interaction with the cannabinoid receptors, the anandamide transporter and fatty acid amidohydrolase.
Reggio PH; Traore H
Chem Phys Lipids; 2000 Nov; 108(1-2):15-35. PubMed ID: 11106780
[TBL] [Abstract][Full Text] [Related]
4. Oxygenated metabolites of anandamide and 2-arachidonoylglycerol: conformational analysis and interaction with cannabinoid receptors, membrane transporter, and fatty acid amide hydrolase.
van der Stelt M; van Kuik JA; Bari M; van Zadelhoff G; Leeflang BR; Veldink GA; Finazzi-Agrò A; Vliegenthart JF; Maccarrone M
J Med Chem; 2002 Aug; 45(17):3709-20. PubMed ID: 12166944
[TBL] [Abstract][Full Text] [Related]
5. Natural and synthetic endocannabinoids and their structure-activity relationships.
Palmer SL; Khanolkar AD; Makriyannis A
Curr Pharm Des; 2000 Sep; 6(13):1381-97. PubMed ID: 10903399
[TBL] [Abstract][Full Text] [Related]
6. Biochemistry and pharmacology of the endocannabinoids arachidonylethanolamide and 2-arachidonylglycerol.
Hillard CJ
Prostaglandins Other Lipid Mediat; 2000 Apr; 61(1-2):3-18. PubMed ID: 10785538
[TBL] [Abstract][Full Text] [Related]
7. Presence and regulation of the endocannabinoid system in human dendritic cells.
Matias I; Pochard P; Orlando P; Salzet M; Pestel J; Di Marzo V
Eur J Biochem; 2002 Aug; 269(15):3771-8. PubMed ID: 12153574
[TBL] [Abstract][Full Text] [Related]
8. Oxidation of the endogenous cannabinoid arachidonoyl ethanolamide by the cytochrome P450 monooxygenases: physiological and pharmacological implications.
Snider NT; Walker VJ; Hollenberg PF
Pharmacol Rev; 2010 Mar; 62(1):136-54. PubMed ID: 20133390
[TBL] [Abstract][Full Text] [Related]
9. The endocannabinoid system: physiology and pharmacology.
Rodríguez de Fonseca F; Del Arco I; Bermudez-Silva FJ; Bilbao A; Cippitelli A; Navarro M
Alcohol Alcohol; 2005; 40(1):2-14. PubMed ID: 15550444
[TBL] [Abstract][Full Text] [Related]
10. Endocannabinoid structure-activity relationships for interaction at the cannabinoid receptors.
Reggio PH
Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):143-60. PubMed ID: 12052032
[TBL] [Abstract][Full Text] [Related]
11. Finding of the endocannabinoid signalling system in Hydra, a very primitive organism: possible role in the feeding response.
De Petrocellis L; Melck D; Bisogno T; Milone A; Di Marzo V
Neuroscience; 1999; 92(1):377-87. PubMed ID: 10392859
[TBL] [Abstract][Full Text] [Related]
12. Discovery and development of endocannabinoid-hydrolyzing enzyme inhibitors.
Minkkilä A; Saario S; Nevalainen T
Curr Top Med Chem; 2010; 10(8):828-58. PubMed ID: 20370710
[TBL] [Abstract][Full Text] [Related]
13. Structure-activity relationships of anandamide, an endogenous cannabinoid ligand.
Khanolkar AD; Makriyannis A
Life Sci; 1999; 65(6-7):607-16. PubMed ID: 10462061
[TBL] [Abstract][Full Text] [Related]
14. Experimental parkinsonism alters endocannabinoid degradation: implications for striatal glutamatergic transmission.
Gubellini P; Picconi B; Bari M; Battista N; Calabresi P; Centonze D; Bernardi G; Finazzi-Agrò A; Maccarrone M
J Neurosci; 2002 Aug; 22(16):6900-7. PubMed ID: 12177188
[TBL] [Abstract][Full Text] [Related]
15. A structure/activity relationship study on arvanil, an endocannabinoid and vanilloid hybrid.
Di Marzo V; Griffin G; De Petrocellis L; Brandi I; Bisogno T; Williams W; Grier MC; Kulasegram S; Mahadevan A; Razdan RK; Martin BR
J Pharmacol Exp Ther; 2002 Mar; 300(3):984-91. PubMed ID: 11861807
[TBL] [Abstract][Full Text] [Related]
16. Cannabimimetic fatty acid derivatives: the anandamide family and other endocannabinoids.
Di Marzo V; Bisogno T; De Petrocellis L; Melck D; Martin BR
Curr Med Chem; 1999 Aug; 6(8):721-44. PubMed ID: 10469888
[TBL] [Abstract][Full Text] [Related]
17. Enzymes of porcine brain hydrolyzing 2-arachidonoylglycerol, an endogenous ligand of cannabinoid receptors.
Goparaju SK; Ueda N; Taniguchi K; Yamamoto S
Biochem Pharmacol; 1999 Feb; 57(4):417-23. PubMed ID: 9933030
[TBL] [Abstract][Full Text] [Related]
18. Endocannabinoids in the central nervous system--an overview.
Fride E
Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):221-33. PubMed ID: 12052038
[TBL] [Abstract][Full Text] [Related]
19. Exploration of biologically relevant conformations of anandamide, 2-arachidonylglycerol, and their analogues using conformational memories.
Barnett-Norris J; Guarnieri F; Hurst DP; Reggio PH
J Med Chem; 1998 Nov; 41(24):4861-72. PubMed ID: 9822555
[TBL] [Abstract][Full Text] [Related]
20. Fatty acid amide hydrolase: an emerging therapeutic target in the endocannabinoid system.
Cravatt BF; Lichtman AH
Curr Opin Chem Biol; 2003 Aug; 7(4):469-75. PubMed ID: 12941421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
